CN1323346A - Tpl－2/cot激酶和使用方法 - Google Patents

Tpl－2/cot激酶和使用方法 Download PDF

Info

Publication number
CN1323346A
CN1323346A CN99812172A CN99812172A CN1323346A CN 1323346 A CN1323346 A CN 1323346A CN 99812172 A CN99812172 A CN 99812172A CN 99812172 A CN99812172 A CN 99812172A CN 1323346 A CN1323346 A CN 1323346A
Authority
CN
China
Prior art keywords
tpl
compounds
activity
compound
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99812172A
Other languages
English (en)
Chinese (zh)
Inventor
H·J·阿伦
R·W·迪克松
J·S·卡门斯
D·维科拉马辛赫
Y·徐
M·P·贝利克
L·H·约翰斯顿
S·C·利
A·萨尔梅隆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abert & Co KG GmbH
Medical Research Council
Original Assignee
BASF SE
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9817930.2A external-priority patent/GB9817930D0/en
Priority claimed from GBGB9827712.2A external-priority patent/GB9827712D0/en
Application filed by BASF SE, Medical Research Council filed Critical BASF SE
Publication of CN1323346A publication Critical patent/CN1323346A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
CN99812172A 1998-08-18 1999-08-13 Tpl－2/cot激酶和使用方法 Pending CN1323346A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9817930.2 1998-08-18
GBGB9817930.2A GB9817930D0 (en) 1998-08-18 1998-08-18 Pathway
GBGB9827712.2A GB9827712D0 (en) 1998-12-16 1998-12-16 Pathway
GB9827712.2 1998-12-16

Publications (1)

Publication Number Publication Date
CN1323346A true CN1323346A (zh) 2001-11-21

Family

ID=26314223

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99812172A Pending CN1323346A (zh) 1998-08-18 1999-08-13 Tpl－2/cot激酶和使用方法

Country Status (22)

Country Link
US (1) US20020099169A1 (enExample)
EP (1) EP1105501A2 (enExample)
JP (1) JP4719831B2 (enExample)
KR (1) KR20010085407A (enExample)
CN (1) CN1323346A (enExample)
AU (1) AU767973B2 (enExample)
BG (1) BG105345A (enExample)
BR (1) BR9913070A (enExample)
CA (1) CA2339036A1 (enExample)
CZ (1) CZ2001625A3 (enExample)
HK (1) HK1041901A1 (enExample)
HU (1) HUP0103797A2 (enExample)
ID (1) ID28955A (enExample)
IL (1) IL141355A0 (enExample)
MX (1) MXPA01001747A (enExample)
NO (1) NO20010786L (enExample)
NZ (1) NZ510313A (enExample)
PL (1) PL347137A1 (enExample)
RU (1) RU2001107122A (enExample)
SK (1) SK2242001A3 (enExample)
TR (2) TR200103840T2 (enExample)
WO (1) WO2000011191A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660906B1 (en) 2000-03-08 2003-12-09 Thomas Jefferson University Tpl2 transgenic knockout mice
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
GB0402661D0 (en) * 2004-02-06 2004-03-10 Medical Res Council TPL2 and its expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514505A (en) * 1995-05-15 1996-05-07 Xerox Corporation Method for obtaining improved image contrast in migration imaging members
UA71889C2 (uk) * 1996-04-02 2005-01-17 Йєда Рісерч Енд Дівелопмент Ко. Лтд. Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування

Also Published As

Publication number Publication date
ID28955A (id) 2001-07-19
TR200103840T2 (tr) 2002-06-21
NO20010786D0 (no) 2001-02-16
PL347137A1 (en) 2002-03-25
IL141355A0 (en) 2002-03-10
NZ510313A (en) 2003-11-28
EP1105501A2 (en) 2001-06-13
CA2339036A1 (en) 2000-03-02
AU5563399A (en) 2000-03-14
BR9913070A (pt) 2001-05-08
RU2001107122A (ru) 2003-04-20
KR20010085407A (ko) 2001-09-07
SK2242001A3 (en) 2001-10-08
BG105345A (en) 2001-12-31
CZ2001625A3 (cs) 2002-02-13
HK1041901A1 (zh) 2002-07-26
JP2002531058A (ja) 2002-09-24
MXPA01001747A (es) 2003-06-06
JP4719831B2 (ja) 2011-07-06
US20020099169A1 (en) 2002-07-25
WO2000011191A2 (en) 2000-03-02
NO20010786L (no) 2001-04-17
HUP0103797A2 (hu) 2003-10-28
WO2000011191A3 (en) 2000-06-08
TR200100624T2 (tr) 2001-08-21
AU767973B2 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
CN1178952C (zh) 编码与感觉转导有关的g-蛋白偶联受体的核酸
Lu et al. Active conformation of the erythropoietin receptor: random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains
Heyeck et al. Lck phosphorylates the activation loop tyrosine of the Itk kinase domain and activates Itk kinase activity
CN1260360C (zh) 脂激酶
US7220723B2 (en) Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
US7696169B2 (en) Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
CN1317010A (zh) 编码与感觉转导有关的g－蛋白偶联受体的核酸
CN1290161A (zh) 核受体配体及配体结合结构域
CN1592625A (zh) G蛋白偶联受体测定
CN1199420A (zh) 细胞周期关卡与pik相关的激酶材料和方法
Lim et al. Structure of the Toxoplasma gondii ROP18 kinase domain reveals a second ligand binding pocket required for acute virulence
CN1132011C (zh) 鉴定能够调节细胞增殖疾病的待测化合物的方法
CN1561223A (zh) 新型药物
CN1254377A (zh) 哺乳动物chk1效应物细胞周期关卡蛋白激酶材料与方法
CN1323346A (zh) Tpl－2/cot激酶和使用方法
CN1295614A (zh) Tnf/ngf受体家族和其它蛋白质的受体的功能的调节剂
US20070032403A1 (en) Crystal structure of the ITK kinase domain
US20030219427A1 (en) TPL-2/COT kinase and methods of use
CN1671843A (zh) 参与转录调控的因子
CN1289524C (zh) 一种人端粒酶活性抑制蛋白及其应用
CN1491281A (zh) 神经调节素及其应用
CN1426468A (zh) Kcnb:新型钾通道蛋白
ZA200102200B (en) TPL-2/cot kinase and methods of use.
CN1412198A (zh) 细胞周期调节蛋白
CN1361822A (zh) Reg－结合蛋白

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: ABBOTT SHARES LIMITED KG CO., LTD.

Free format text: FORMER OWNER: BASF COMPANY

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20030807

Address after: Ludwigshafen, Germany

Applicant after: Abert GmbH & Co. KG

Co-applicant after: Medical Res Council

Address before: Ludwigshafen, Germany

Applicant before: BASF AG

Co-applicant before: Medical Res Council

AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1041901

Country of ref document: HK